Hypertriglyceridemia-Induced Acute Pancreatitis, Euglycemic Diabetic Ketoacidosis and COVID-19 Infection in a Patient With Type 2 Diabetes Taking a Sodium-Glucose Cotransporter 2 Inhibitor

Recent landmark trials have increased the use of sodium-glucose cotransporter 2 inhibitors (SGLT-2i) in patients with type 2 diabetes (T2D). A rare but serious side effect of SGLT-2i is euglycemic diabetic ketoacidosis (euDKA), which usually occurs in the setting of acute illness such as the coronav...

Descripción completa

Detalles Bibliográficos
Autores principales: Acevedo-Mendez, Bernardo A, Ye, Yuting, Hajizadeh, Negin, Myers, Alyson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609612/
https://www.ncbi.nlm.nih.gov/pubmed/34853772
http://dx.doi.org/10.7759/cureus.19828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609612/
https://www.ncbi.nlm.nih.gov/pubmed/34853772
http://dx.doi.org/10.7759/cureus.19828

Ejemplares similares